261
Özkan, A., Kapiteijn, E., van den Bos, F., Aarts, M. J.B., van den Berkmortel, F. W.P.J., Blank, C. U., Bloem, M., Blokx, W. A.M., Boers-Sonderen, M. J., Bonenkamp, J. J., van den Eertwegh, A. J.M., de Groot, J. W.B., Haanen, J. B., Holtslag, C. E., Hospers, G. A.P., Piersma, D., van Rijn, R. S., Stevense-den Boer, A. M., Suijkerbuijk, K. P.M., van der Veldt, A. A.M., Vreugdenhil, G., Wouters, M. W.J.M., Portielje, J. E.A., de Glas, N. A.
Veröffentlicht in: Özkan , A , Kapiteijn , E , van den Bos , F , Aarts , M J B , van den Berkmortel , F W P J , Blank , C U , Bloem , M , Blokx , W A M , Boers-Sonderen , M J , Bonenkamp , J J , van den Eertwegh , A J M , de Groot , J W B , Haanen , J B , Holtslag , C E , Hospers , G A P , Piersma , D , van Rijn , R S , Stevense-den Boer , A M , Suijkerbuijk , K P M , van der Veldt , A A M , Vreugdenhil , G , Wouters , M W J M , Portielje , J E A & de Glas , N A 2024 , ' Adjuvant immunotherapy in older patients with stage III and resected stage IV melanoma : Toxicity and recurrence-free survival outcomes from the Dutch melanoma treatment registry ' , European Journal of Cancer , vol. 212 , 115056 . https://doi.org/10.1016/j.ejca.2024.115056;
2024
Veröffentlicht in: Özkan , A , Kapiteijn , E , van den Bos , F , Aarts , M J B , van den Berkmortel , F W P J , Blank , C U , Bloem , M , Blokx , W A M , Boers-Sonderen , M J , Bonenkamp , J J , van den Eertwegh , A J M , de Groot , J W B , Haanen , J B , Holtslag , C E , Hospers , G A P , Piersma , D , van Rijn , R S , Stevense-den Boer , A M , Suijkerbuijk , K P M , van der Veldt , A A M , Vreugdenhil , G , Wouters , M W J M , Portielje , J E A & de Glas , N A 2024 , ' Adjuvant immunotherapy in older patients with stage III and resected stage IV melanoma : Toxicity and recurrence-free survival outcomes from the Dutch melanoma treatment registry ' , European Journal of Cancer , vol. 212 , 115056 . https://doi.org/10.1016/j.ejca.2024.115056;
2024
262
263
264
265
266
267
268
Kuppen, Malou C.P., Westgeest, Hans M., van den Eertwegh, Alfons J.M., van Moorselaar, Reindert J.A., van Oort, Inge M., Tascilar, Metin, Mehra, Niven, Lavalaye, Jules, Somford, Diederik M., Aben, Katja K.H., Bergman, Andre M., de Wit, Ronald, van den Bergh, A. C. M. (Fons), de Groot, Carin A.Uyl, Gerritsen, Winald R.
Veröffentlicht in: Kuppen , M C P , Westgeest , H M , van den Eertwegh , A J M , van Moorselaar , R J A , van Oort , I M , Tascilar , M , Mehra , N , Lavalaye , J , Somford , D M , Aben , K K H , Bergman , A M , de Wit , R , van den Bergh , A C M , de Groot , C A U & Gerritsen , W R 2022 , ' Symptomatic Skeletal Events and the Use of Bone Health Agents in a Real-World Treated Metastatic Castration Resistant Prostate Cancer Population : Results From the CAPRI-Study in the Netherlands ' , Clinical genitourinary cancer , vol. 20 , no. 1 , pp. 43-52 . https://doi.org/10.1016/j.clgc.2021.10.008;
2022
Veröffentlicht in: Kuppen , M C P , Westgeest , H M , van den Eertwegh , A J M , van Moorselaar , R J A , van Oort , I M , Tascilar , M , Mehra , N , Lavalaye , J , Somford , D M , Aben , K K H , Bergman , A M , de Wit , R , van den Bergh , A C M , de Groot , C A U & Gerritsen , W R 2022 , ' Symptomatic Skeletal Events and the Use of Bone Health Agents in a Real-World Treated Metastatic Castration Resistant Prostate Cancer Population : Results From the CAPRI-Study in the Netherlands ' , Clinical genitourinary cancer , vol. 20 , no. 1 , pp. 43-52 . https://doi.org/10.1016/j.clgc.2021.10.008;
2022
269
270